Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 2
1984 3
1985 6
1986 9
1987 3
1988 4
1989 5
1990 10
1991 6
1992 7
1993 6
1994 5
1995 5
1996 9
1997 5
1998 2
1999 2
2001 2
2003 1
2005 1
2006 1
2018 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Second-generation antihistamines: a comparative review.
Slater JW, Zechnich AD, Haxby DG. Slater JW, et al. Drugs. 1999 Jan;57(1):31-47. doi: 10.2165/00003495-199957010-00004. Drugs. 1999. PMID: 9951950
This article evaluates second-generation antihistamines, including acrivastine, astemizole, azelastine, cetirizine, ebastine, fexofenadine, ketotifen, loratadine, mizolastine and terfenadine, for significant features that affect choice. ...Most of the agents reviewed are m …
This article evaluates second-generation antihistamines, including acrivastine, astemizole, azelastine, cetirizine, ebastine, fexofen …
Astemizole-D causes less sleep impairment than loratadine-D.
Janssens MM, Lins RL. Janssens MM, et al. J Int Med Res. 1995 May-Jun;23(3):167-74. doi: 10.1177/030006059502300303. J Int Med Res. 1995. PMID: 7649340 Clinical Trial.
This randomized, double-blind, double-dummy, parallel-group trial was initiated to evaluate and compare the tolerability of once-daily astemizole-D capsules (10 mg astemizole/240 mg pseudoephedrine) and twice-daily loratadine-D tablets (5 mg loratadine/120 mg pseudo …
This randomized, double-blind, double-dummy, parallel-group trial was initiated to evaluate and compare the tolerability of once-daily as
[Efficacy and safety of astemizole in the treatment of allergic rhinitis and urticaria: a systematic review with meta-analysis].
Gutiérrez Castrellón P, Ramírez Mayans J, López Pérez G. Gutiérrez Castrellón P, et al. Rev Alerg Mex. 2005 May-Jun;52(3):113-26. Rev Alerg Mex. 2005. PMID: 16158785 Review. Spanish.
OBJECTIVE: To compare astemizole with other first or second generation antihistaminics in the treatment of allergic rhinitis or urticaria. ...MATERIAL AND METHODS: 36 controlled, randomized, clinical, double or simple blind tests were made in 6,446 patients; 4,513 of them …
OBJECTIVE: To compare astemizole with other first or second generation antihistaminics in the treatment of allergic rhinitis or urtic …
Astemizole in combination with pseudoephedrine in the treatment of seasonal allergic rhinitis.
Simola M, Böss I, Holopainen E, Malmberg H, Ruoppi P, Seppä J, Siivonen L, Suonpää J, Piepponen T. Simola M, et al. Rhinology. 1996 Mar;34(1):21-3. Rhinology. 1996. PMID: 8739863 Clinical Trial.
The efficacy and side effects of once-daily astemizole-D, a combination of 10 mg astemizole and 240 mg pseudoephedrine, were compared with those of twice-daily brompheniramine-D, a combination of 12 mg brompheniramine and 50 mg phenylpropanolamine (Lunerin), in 64 p …
The efficacy and side effects of once-daily astemizole-D, a combination of 10 mg astemizole and 240 mg pseudoephedrine, were c …
Astemizole in the treatment of hay fever.
Malmberg H, Holopainen E, Grahne B, Binder E, Savolainen S, Sundberg S. Malmberg H, et al. Allergy. 1983 May;38(4):227-31. doi: 10.1111/j.1398-9995.1983.tb01615.x. Allergy. 1983. PMID: 6408940 Clinical Trial.
A double-blind parallel trial of astemizole, pheniramine and placebo was carried out in 51 patients with hay fever. Astemizole is a new potent H1-antihistamine with long duration of action but devoid of central activity. ...
A double-blind parallel trial of astemizole, pheniramine and placebo was carried out in 51 patients with hay fever. Astemizole
A comparison of astemizole and chlorpheniramine in dermographic urticaria.
Krause LB, Shuster S. Krause LB, et al. Br J Dermatol. 1985 Apr;112(4):447-53. doi: 10.1111/j.1365-2133.1985.tb02319.x. Br J Dermatol. 1985. PMID: 3922395 Clinical Trial.
Subjective itch (10 cm line) and frequency of dermographic episodes were also reduced more by astemizole than by chlorpheniramine. The effect of astemizole was greater at 4 weeks than at 2 weeks, whereas the effect of chlorpheniramine had decreased at 4 weeks. The e …
Subjective itch (10 cm line) and frequency of dermographic episodes were also reduced more by astemizole than by chlorpheniramine. Th …
Astemizole and cetirizine in the treatment of seasonal allergic rhinitis: a comparative double-blind, multicentre study.
Rijntjes E, Ghys L, Rihoux JP. Rijntjes E, et al. J Int Med Res. 1990 May-Jun;18(3):219-24. doi: 10.1177/030006059001800306. J Int Med Res. 1990. PMID: 1972927 Clinical Trial.
In a double-blind, multicentre trial, 105 patients with seasonal allergic rhinitis were treated with 10 mg astemizole or 10 mg cetirizine once daily for 4 days. Patients were thereafter allowed to change their treatment if not satisfied with the clinical efficacy. In the c …
In a double-blind, multicentre trial, 105 patients with seasonal allergic rhinitis were treated with 10 mg astemizole or 10 mg cetiri …
A study of the interaction between dirithromycin and astemizole in healthy adults.
Bachmann K, Sullivan TJ, Reese JH, Jauregui L, Miller K, Scott M, Stotka J, Harris J. Bachmann K, et al. Am J Ther. 1997 Feb-Mar;4(2-3):73-9. doi: 10.1097/00045391-199702000-00004. Am J Ther. 1997. PMID: 10423595 Clinical Trial.
On the morning of the fourth dose of either dirithromycin or placebo each subject ingested a single 30-mg oral dose (three 10-mg tablets) of astemizole. The disposition kinetics of both astemizole and its major metabolite, N-desmethylastemizole, were characterized a …
On the morning of the fourth dose of either dirithromycin or placebo each subject ingested a single 30-mg oral dose (three 10-mg tablets) of …
Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled, comparative trial.
Breneman D, Bronsky EA, Bruce S, Kalivas JT, Klein GL, Roth HL, Tharp MD, Treger C, Soter N. Breneman D, et al. J Am Acad Dermatol. 1995 Aug;33(2 Pt 1):192-8. doi: 10.1016/0190-9622(95)90233-3. J Am Acad Dermatol. 1995. PMID: 7622644 Free article. Clinical Trial.
BACKGROUND: Cetirizine and astemizole have been shown to be safe and effective in the treatment of patients with chronic idiopathic urticaria. ...Both active treatments were well tolerated, and the incidence of somnolence did not differ statistically between cetirizine (14 …
BACKGROUND: Cetirizine and astemizole have been shown to be safe and effective in the treatment of patients with chronic idiopathic u …
Astemizole, a potent histamine H1-receptor antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels.
Howarth PH, Emanuel MB, Holgate ST. Howarth PH, et al. Br J Clin Pharmacol. 1984 Jul;18(1):1-8. doi: 10.1111/j.1365-2125.1984.tb05013.x. Br J Clin Pharmacol. 1984. PMID: 6146346 Free PMC article. Clinical Trial.
The efficacy of astemizole, a new, long acting, oral histamine H1-receptor antagonist was compared to placebo for the treatment of allergic rhinitis and conjunctivitis during the grass pollen season of 1982. ...The absence of effect on nasal blockage was confirmed by paral …
The efficacy of astemizole, a new, long acting, oral histamine H1-receptor antagonist was compared to placebo for the treatment of al …
97 results